Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rueyming Loor"'
Publikováno v:
Therapeutic drug monitoring. 26(1)
A nonextraction homogeneous immunoassay (CEDIA® Cyclosporine Plus Assay) has been developed for the measurement of cyclosporine in predose (trough) and post-dose (C2 to C8) whole-blood samples. The method includes a low-range assay that measures cyc
Publikováno v:
Journal of analytical toxicology. 26(5)
Using Microgenics unique technology, cloned enzyme donor immunoassay (CEDIA), the multiplex assay (CEDIA Amphetamines/Ecstasy) has been developed for the detection of amphetamine, methamphetamine, and ecstasy drugs at cutoff level either of 500 ng/mL
Autor:
Lawrence D. Papsidero, T. M. Chu, E. D. Holyoke, Manabu Kuriyama, Rueyming Loor, R. A. Berjian, Takuma Nemoto, Ronald G. Vincent, T Shimano, Harold O. Douglass
Publikováno v:
Cancer. 47:1602-1613
A pancreas cancer-associated antigen (PCAA) was identified and isolated from ascites fluid of human pancreatic cancer. Purified PCAA was homogeneous as determined by polyacrylamide gel electrophoresis. PCAA was a glycoprotein with a molecular weight
Autor:
Jan J. Nicolai, Hideo Inaji, Guido N. J. Tytgat, T. Ming Chu, Manabu Kuriyama, Mary Lou Manzo, R. A. Berjian, Harold O. Douglass, Rueyming Loor
Publikováno v:
Clinica Chimica Acta. 117:251-258
A sensitive sandwich-type enzyme immunosorbent assay has been developed for quantitation of a new human pancreas-specific antigen (PaA). With this method, PaA at a concentration as low as 0.8 ng/ml can be detected. The assay was reproducible as shown
Publikováno v:
Proceedings of the National Academy of Sciences. 83:3166-3170
The complete amino acid sequence of the prostate-specific antigen (PA) from human seminal plasma has been determined from analyses of the peptides generated by cyanogen bromide, hydroxylamine, endoproteinases Arg-C and Lys-C. The single polypeptide c
Publikováno v:
Cancer letters. 14(1)
By a specific immunochemical measurement, the activity of prostatic acid phosphatase (PAP) in prostate cancer was found to be about 25%, on average, based on micrograms DNA or per cell, of that in normal prostate or benign prostatic hypertrophy (BPH)
Autor:
Lawrence D. Papsidero, T Shimano, T. Ming Chu, Lance Van Dusen, Mary Lou Manzo, Jan J. Nicolai, Rueyming Loor, Guido N. J. Tytgat
Publikováno v:
Biochimica et biophysica acta. 668(2)
A pancreas-specific antigen was identified by immunologic techniques and purified from saline extract of human pancreas. The purified pancreas-specific antigen was shown to be homogeneous by polyacrylamide gel electrophoresis under both denaturing an
Publikováno v:
Biochemical and biophysical research communications. 123(2)
Human prostate-specific antigen has been found to exhibit a mild activity of protease at neutral pH. This finding is based on two observations: a proteolytic activity was always associated with the antigen fractions during purification, and the prote
Autor:
M. C. Wang, Manabu Kuriyama, N. H. Slack, Papsidero Ld, H. Inaji, Gerald P. Murphy, T.M. Chu, C. L. Lee, Carl S. Killian, Rueyming Loor, T. Nishiura, M. F. Lin
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Serum prostate-specific antigen and prostatic acid phosphatase were simultaneously evaluated in 22 healthy males, 29 patients with benign prostatic hypertrophy, and 192 patients with prostate cancers at various stages as well as in 30 patients with c